Also, our group demonstrated chronic activation of p53 and its target genes promyelocytic leukemia (PML) and growth arrest and DNA damage-inducible protein alpha (GADD45) in normally pigmented biopsies of vitiligo patients, highlighting the intrinsic nature of vitiligo-associated damage and its independence from pigment loss [38]. The gene discussed is PML; the disease is vitiligo.